Cargando…
Inhibition of Glutamine Synthetase: A Potential Drug Target in Mycobacterium tuberculosis
Tuberculosis is an infectious disease caused by Mycobacterium tuberculosis. Globally, tuberculosis is second only to AIDS in mortality and the disease is responsible for over 1.3 million deaths each year. The impractically long treatment schedules (generally 6–9 months) and unpleasant side effects o...
Autores principales: | Mowbray, Sherry L., Kathiravan, Muthu K., Pandey, Abhishek A., Odell, Luke R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6271674/ https://www.ncbi.nlm.nih.gov/pubmed/25162957 http://dx.doi.org/10.3390/molecules190913161 |
Ejemplares similares
-
Trisubstituted Imidazoles
as Mycobacterium tuberculosis Glutamine Synthetase
Inhibitors†
por: Gising, Johan, et al.
Publicado: (2012) -
An Inhibitor of Exported Mycobacterium tuberculosis Glutamine Synthetase Selectively Blocks the Growth of Pathogenic Mycobacteria in Axenic Culture and in Human Monocytes: Extracellular Proteins as Potential Novel Drug Targets
por: Harth, Günter, et al.
Publicado: (1999) -
Differential inhibition of adenylylated and deadenylylated forms of M. tuberculosis glutamine synthetase as a drug discovery platform
por: Theron, A., et al.
Publicado: (2017) -
Identification of Concomitant Inhibitors against Glutamine Synthetase and Isocitrate Lyase in Mycobacterium tuberculosis from Natural Sources
por: Chanda, Anesha, et al.
Publicado: (2022) -
Glutamine Synthetase as a Therapeutic Target for Cancer Treatment
por: Kim, Go Woon, et al.
Publicado: (2021)